DoJ Contests Assa Abloy's Move To Hide Anti-Competitive Evidence

By IPVM, Published Sep 29, 2022, 08:43am EDT (Info+)

The US Department of Justice is opposing Assa Abloy's move to hide from the public evidence the DoJ obtained showing Assa's alleged anti-competitive practices.

IPVM Image

In this report, IPVM examines the legal arguments and whether the courts will decide to allow or seal this evidence.

**********

**** ***** ** * ******* ******** conglomerate **** ***** *****, *****, ****** systems, *** ***** ***** ** ******** and **** ********. *** ****** ******** aims ** ******* * **% ****** rate ***** ****, ********* ******* *** acquisition ** ****** *** ***********.

** ********* ** ****, **** **************** ****** '******** & **** ***********' (HHI) ******** ** * $*.* ******* USD ****. ** ********* **, ****,*** ********** ** ******* (***) ***** a ******************* **** *** **** ** ******* due ** ****-***** ********.

*** *** ********* ******** * ********** of ********** **** **** ***** *** Nico ******* ****** **** **** ****** to "**** ** *** ***********" ****** the **** ******* "*** ****."

*** ********* ******** ********** ***** ******** of ****-*********** ********, *********:

  • **** ********** ********* ****, ** * result ** *** ***********, *** ** its *********** **** ******** ****** ***** be “** * ****** ******* *********** position *** *** ****** ** ******** prices.”
  • ** *******’* ***** ******** ******** ***** the ******** *********** *** *********, *** combination ** ***** *** ******* “****** be **** ** ******** ***** ******** in *** *******.”
  • *********** ***** *** ******** *********** *** publicly *********, ******** *** ***** ********* internally *********** **** *** ****** **** would “[*]** * ****** **[*******] *******” and “**** ***** ** *** **** end,” ******* ********* **** ********* ***** product *****, **** ** **** ******** for ******* *****. **** ********** ********** sharply **** *******’* ***-****** ******** ** expand *** ******* ********* ** ***** to ******* ******* *****.

Assa's ****** ** ****

**** ***** ********* ******** * *********** ***** ** **** *** ********** of ******* "******** *** ********* **** the ****** ******" *** "****** ** under ****."

*** ********* ** **** *********** ** the ****** ****** ******** *** **********’* nondisclosure *********** ***** *** *** [****-*****-****** Antitrust ************] ***

*** ******* ****** **** ***** *** HSR ***, *********** ******** ****** * premerger ************ ****** **** ************ **** treated ** ************. ** ****'* ****, it ********* ******** ******** ***********, ******* information, ******* *********** ********, *** **** and ******* ***********.

**** ******** **** * ********* ** HSR ****** *** *** ********** ** sensitive ********* ***********:

*** ********** ***** ****** ** *** other, ***** ****** ********** “** *** be ******** ** *** ************** ** judicial ****** ** **********.”

*******, *** ******* ******** ** *** DoJ ***** *** **** ******* ** making **** *********** ******:

******, *** “******** **********” ********* ***** sense **** ** *** ***** (** an ********* ************** ******) ** *** arbiter ** **** *** ** ******** publicly

******, **** ******* *** *** ******* that * ***** ****** ********* ******* or *** **** *********** ** ******** to *** "******** **********" ****** ** decides ******* ** *** ** *** be *********.

DOJ ********

** * ******** ***** ** ********* 26, ****, *** ********** ** ******* opposes **** *****'* **** ** **** the ********* *** ****** *** ****** complaint ****** ****** ******.

*** *** ******** **** ***** ** a ********** **** *** *** ****** to ****** *** *********:

******* **** **** ** ** *********** action ** *** ****** ****** ** preserve *********** *** ******* *** ********* of ******** *********, ***** ** ** especially ********** **** *** ****** ****** to *** *********.

*** ********** ** ******* **** ****** that **** ****** ** ***** *** alleged ******** ** ****-*************** ****** ****** sealed ***** *** ***-********** *********** ** the *** ****-*****-****** ********* ************ *** of **** (“*** ***”).

*** *** ******* **** **** *** not ******** *** ******** ****** ** to *** *** ********* ***** **** the *******'* *********** ********:

** ***** ***** ****** ***** [*** fourth] ******* [******], ********** **** ************ identify *** ************ ********* *********** **** seek ** **** “*** ******* *** its ********** ***** **** ***** *********** standing.”

********, *** ****** **** **** **** is ******* ** ******* *********** **** is ******* ******** *********:

******* *********** **** ** “******* ******* accessible ** *** ********” ***** ** “both ********* *** ***********.”

*******

*** ********** ** *******'* ********** *********** the ********** ** ************ ** *** face ** ****** *********** *** *********. While ********* *** ********** ******** ** obscure ***** ********** *** ********, ** the *** ******, ***** ** * compelling **** ** ****** ****** ******** practices ** *** ******.

********, *** ************ ** *********** ** the ******** *********** *********** **** ********* to **** *********** **** *** ******.

Comments (0)

Login to read this IPVM report.
Why do I need to log in?
IPVM conducts reporting, tutorials and software funded by subscriber's payments enabling us to offer the most independent, accurate and in-depth information.
Loading Related Reports